Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis

Clinical Immunology

Volumn 141, Issue 3, 2011, Pages 328-337

  Zhou, Bin ^a   Yuan, Jingdong ^b   Zhou, Yixuan ^a   Ghawji, Maher ^a   Deng, Yun Ping ^a   Lee, Austin J ^a   Lee, Albert J ^a   Nair, Usha ^a   Kang, Andrew H ^a   Brand, David D ^a   Yoo, Tai June ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Wuhan Pulmonary Hospital   (China)

Author keywords

Adipose derived mesenchymal stem cells; Collagen induced arthritis; Regulatory T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL;

ADIPOSE TISSUE; ANIMALS; ARTHRITIS, EXPERIMENTAL; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED DBA; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 81355146699     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.08.014     Document Type: Article

References (33)

1. Fournier C. Where do T cells stand in rheumatoid arthritis?. Joint Bone Spine 2005 Dec, 72(6):527-532.
2. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
3. González M.A., Gonzalez-Rey E., Rico L., Büscher D., Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 2009 Apr, 60(4):1006-1019.
4. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
5. + regulatory T cells. Arthritis Rheum. 2005, 52:2212-2221.
6. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum. 2007 Mar, 56(3):732-742.
7. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
8. Liu Z.J., Zhuge Y., Velazquez O.C. Trafficking and differentiation of mesenchymal stem cells. J. Cell. Biochem. 2009 Apr 15, 106(6):984-991.
9. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
10. Nasef A., Ashammakhi N., Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen. Med. 2008 Jul, 3(4):531-546.
11. Noël D., Djouad F., Bouffi C., Mrugala D., Jorgensen C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk. Lymphoma 2007 Jul, 48(7):1283-1289.
12. Djouad F., Bouffi C., Ghannam S., Noël D., Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat. Rev. Rheumatol. 2009 Jul, 5(7):392-399.
13. Glennie S., Soeiro I., Dyson P.J., Lam W., Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821-2827.
14. Wehner R., Wehrum D., Bornhäuser M., Zhao S., Schäkel K., Bachmann M.P., Platzbecker U., Ehninger G., Rieber E.P., Schmitz M. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica 2009 Aug, 94(8):1151-1156.
15. Locke M., Windsor J., Dunbar P.R. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J. Surg. 2009, 79(4):235-244.
16. Bouffi C., Djouad F., Mathieu M., Noël D., Jorgensen C. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?. Rheumatology (Oxford) 2009 Oct, 48(10):1185-1189.
17. Yañez R., Lamana M.L., García-Castro J., Colmenero I., Ramírez M., Bueren J.A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006 Nov, 24(11):2582-2591.
18. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005 Mar 1, 105(5):2214-2219.
19. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., Taureau C., Cousin B., Abbal M., Laharrague P., Penicaud L., Casteilla L., Blancher A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 2005 Apr, 129(1):118-129.
20. Miller E.J. Isolation and characterization of a collagen from chick cartilage containing three identical alpha chains. Biochemistry 1971 Apr 27, 10(9):1652-1659.
21. Brand D.D., Latham K.A., Rosloniec E.F. Collagen-induced arthritis. Nat. Protoc. 2007, 2(5):1269-1275.
22. Ra J.C., Shin I.S., Kim S.H., Kang S.K., Kang B.C., Lee H.Y., Kim Y.J., Jo J.Y., Yoon E.J., Choi H.J., Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011 Aug, 20(8):1297-1308.
23. Myers L.K., Stuart J.M., Kang A.H. A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J. Immunol. 1989, 143:3976-3980.
24. Ellsworth J.L., Hamacher N., Harder B., Bannink K., Bukowski T.R., Byrnes-Blake K., Underwood S., Oliver C., Waggie K.S., Noriega C., Hebb L., Rixon M.W., Lewis K.E. Recombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis. J. Immunol. 2009 Jun 1, 182(11):7272-7279.
25. Battaglia M., Gianfrani C., Gregori S., Roncarolo M.G. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann. N. Y. Acad. Sci. 2004 Dec, 1029:142-153.
26. Levings M.K., Bacchetta R., Schulz U., Roncarolo M.G. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 2002 Dec, 129(4):263-276.
27. Lloyd C.M., Hawrylowicz C.M. Regulatory T cells in asthma. Immunity 2009 Sep 18, 31(3):438-449.
28. + regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007, 92:881-888.
29. + hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J. Immunol. 2008, 180:1598-1608.
30. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005 Apr, 90(4):516-525.
31. Gonzalez-Rey E., Gonzalez M.A., Varela N., O'Valle F., Hernandez-Cortes P., Rico L., Büscher D., Delgado M. Human adipose mesenchymal cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann. Rheum. Dis. 2010 Jan, 69(1):241-248.
32. Augello A., Tasso R., Negrini S.M., Cancedda R., Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 2007 Apr, 56(4):1175-1186.
33. Holladay C., Power K., Sefton M., O'Brien T., Gallagher W.M., Pandit A. Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells in vivo. Mol. Ther. 2011 May, 19(5):969-978.